Literature DB >> 15213627

Updated population-based review of carcinoid tumors.

Melinda A Maggard1, Jessica B O'Connell, Clifford Y Ko.   

Abstract

OBJECTIVE: To determine the population-based incidence, anatomic distribution, and survival rates of gastrointestinal carcinoid tumors.
BACKGROUND: Carcinoid tumors arise from neuroendocrine cells and may develop in almost any organ. Many textbooks and articles represent single institution studies and report varying incidence rates, anatomic distribution of tumors, and patient survival rates. Population-based statistics remain largely unknown.
METHODS: Data was obtained from the National Cancer Institute Surveillance, Epidemiology, and End Results program (1973 to 1997). Incidence rates, distribution, and 5-year survival rates were analyzed. Multivariate Cox regression was used to identify predictors of survival using age, race/ethnicity, gender, and tumor characteristics (size, lymph node status, and stage).
RESULTS: Of the 11,427 cases analyzed, the average age was 60.9 years, and 54.2% were female. The overall incidence rates for carcinoid tumors have increased significantly over the past 25 years, although rates for some sites have decreased (eg, appendix). The gastrointestinal tract accounted for 54.5% of the tumors. Within the gastrointestinal tract, the small intestine was the most common site (44.7%), followed by the rectum (19.6%), appendix (16.7%), colon (10.6%), and stomach (7.2%). The 5-year survival rates for the most common gastrointestinal sites were stomach (75.1%), small intestine (76.1%), appendix (76.3%), and rectum (87.5%).
CONCLUSIONS: Using national, population-based cancer registry data, this study demonstrates that (1) incidence rates for carcinoid tumors have changed, (2) the most common gastrointestinal site is not the appendix (as is often quoted), but the small intestine, followed in frequency by the rectum, and (3) survival rates differ between individual anatomic sites.

Entities:  

Mesh:

Year:  2004        PMID: 15213627      PMCID: PMC1356383          DOI: 10.1097/01.sla.0000129342.67174.67

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

1.  Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients.

Authors:  J W Gamel; R L Vogel
Journal:  Stat Methods Med Res       Date:  2001-10       Impact factor: 3.021

2.  Rectal carcinoids: the most frequent carcinoid tumor.

Authors:  A B Jetmore; J E Ray; J B Gathright; K M McMullen; T C Hicks; A E Timmcke
Journal:  Dis Colon Rectum       Date:  1992-08       Impact factor: 4.585

3.  Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management.

Authors:  Mark S Talamonti; Laura H Goetz; Sambasiva Rao; Raymond J Joehl
Journal:  Arch Surg       Date:  2002-05

4.  Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry.

Authors:  G H Ballantyne; P E Savoca; J T Flannery; M H Ahlman; I M Modlin
Journal:  Cancer       Date:  1992-05-15       Impact factor: 6.860

5.  Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.

Authors:  R M Merrill; R Capocaccia; E J Feuer; A Mariotto
Journal:  Int J Epidemiol       Date:  2000-04       Impact factor: 7.196

Review 6.  Review article: current status of gastrointestinal carcinoids.

Authors:  J M Läuffer; T Zhang; I M Modlin
Journal:  Aliment Pharmacol Ther       Date:  1999-03       Impact factor: 8.171

7.  Carcinoid tumors. An analysis of 2,837 cases.

Authors:  J D Godwin
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

8.  Information gained from linking SEER Cancer Registry Data to state-level hospital discharge abstracts. Surveillance, Epidemiology, and End Results.

Authors:  J M Brooks; E Chrischilles; S Scott; J Ritho; S Chen-Hardee
Journal:  Med Care       Date:  2000-11       Impact factor: 2.983

9.  Gastrointestinal carcinoid tumors: long-term prognosis for surgically treated patients.

Authors:  J A Söreide; J A van Heerden; G B Thompson; C Schleck; D M Ilstrup; M Churchward
Journal:  World J Surg       Date:  2000-11       Impact factor: 3.352

Review 10.  Carcinoid tumors of the gut. Our experience over three decades and review of the literature.

Authors:  J B Marshall; G Bodnarchuk
Journal:  J Clin Gastroenterol       Date:  1993-03       Impact factor: 3.062

View more
  145 in total

1.  Prevalence of Small Intestine Carcinoid Tumors: A US Population-Based Study 2012-2017.

Authors:  Mohannad Abou Saleh; Emad Mansoor; Mohammad Anindo; Gerard Isenberg
Journal:  Dig Dis Sci       Date:  2018-12-05       Impact factor: 3.199

2.  Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience.

Authors:  William C Chen; Richard R P Warner; Stephen C Ward; Noam Harpaz; Celia M Divino; Steven H Itzkowitz; Michelle K Kim
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

3.  Tumor size and depth predict rate of lymph node metastasis in colon carcinoids and can be used to select patients for endoscopic resection.

Authors:  Riad H Al Natour; Mandeep S Saund; Vivian M Sanchez; Edward E Whang; Ashish M Sharma; Qin Huang; Valia A Boosalis; Jason S Gold
Journal:  J Gastrointest Surg       Date:  2011-12-06       Impact factor: 3.452

4.  79-year-old woman with forgetfulness.

Authors:  William C Palmer; Jennifer A Crozier; Olga M Petrucelli
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

5.  Recurrent small bowel obstruction in an elderly woman.

Authors:  T S Chandrasekar; M Murugesh; M Murthy; B S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2010-03

6.  Primary aldosteronism due to adrenocortical adenoma with concurrent ileum carcinoid tumor: case report.

Authors:  L Zinnamosca; L Petramala; D Cotesta; C Marinelli; S Sciomer; G Cavallaro; A Ciardi; R Massa; G De Toma; S Filetti; C Letizia
Journal:  Endocrine       Date:  2010-12       Impact factor: 3.633

Review 7.  Rectal carcinoids: a systematic review.

Authors:  Frank D McDermott; Anna Heeney; Danielle Courtney; Helen Mohan; Des Winter
Journal:  Surg Endosc       Date:  2014-03-01       Impact factor: 4.584

8.  p21 and p27 immunoexpression in gastric well differentiated endocrine tumors (ECL-cell carcinoids).

Authors:  Basak Doganavsargil; Banu Sarsik; Fatma Secil Kirdok; Ahmet Musoglu; Muge Tuncyurek
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

9.  Primary Renal Carcinoid Tumor: Report of Two Cases.

Authors:  Ramzi Jabaji; Tyler Kern; Dejun Shen; William Chu; Madhur Merchant
Journal:  Perm J       Date:  2020-03-13

10.  Postoperative radiotherapy for residual tumor of primary mediastinal carcinoid teratoma.

Authors:  Lingli Tu; Lan Sun; Yu Zhou; Youling Gong; Jianxin Xue; Jun Gao; You Lu; Yongsheng Wang
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.